YOLFTbeta
Sea Mild Biotechnology Co., Ltd.

Sea Mild Biotechnology Co., Ltd.

7516 · TWO · Consumer Defensive / Household & Personal Products

7.35TWD-0.14 (-1.87%)

Price History

Full chart

Market Stats

Previous Close7.49
Open7.60
Day Range7.33 – 7.71
52-Week Range7.91 – 14.50
Volume10.31K
Market Cap160.26M
P/E (TTM)23.71
Forward P/E0.00
EPS0.35
Dividend Yield0.00%
Beta-0.76
50-Day Avg8.44
200-Day Avg9.33

About

Sea Mild Biotechnology Co., Ltd. manufactures and sells paints, coatings, and cleaning detergents in Taiwan. It offers laundry, household, and personal detergent, as well as epidemic prevention products under the Sea Mild Biotech brand name. Sea Mild Biotechnology Co., Ltd. was established in 2007 and is headquartered in Taoyuan City, Taiwan.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMr. Yunjun Luo
  • HeadquartersNo. 43, Guanye East Road, Taoyuan City, Taiwan, 324017, Taiwan
  • Websitehttps://www.seamild.com.tw

Leadership

  • Mr. Yunjun LuoChairman & Manager
  • Ms. Yufen WeiAccounting Supervisor

Financials

Income Statement

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue227.71M168.25M215.07M214.14M207.88M163.82M202.65M257.02M318.82M341.94M
Growth (%)--26.11%+27.83%-0.43%-2.92%-21.20%+23.71%+26.83%+24.05%+7.25%
Cost of Revenue173.25M141.37M158.08M211.24M184.95M150.87M174.59M200.65M227.54M252.74M
Gross Profit54.47M26.89M56.99M2.90M22.93M12.95M28.06M56.37M91.28M89.20M
Gross Margin23.92%15.98%26.50%1.36%11.03%7.91%13.85%21.93%28.63%26.09%
Operating Expense87.83M57.44M64.59M105.44M59.51M44.94M40.04M51.54M69.00M81.98M
Operating Income-33.36M-30.55M-7.60M-102.53M-36.57M-31.99M-11.98M4.83M22.28M7.22M
Operating Margin-14.65%-18.16%-3.53%-47.88%-17.59%-19.53%-5.91%1.88%6.99%2.11%
EBITDA-26.35M22.27M-2.34M-121.26M-25.25M-20.33M-5.63M21.58M53.25M34.65M
EBITDA Margin-11.57%13.24%-1.09%-56.62%-12.14%-12.41%-2.78%8.40%16.70%10.13%
Net Income-29.84M17.84M66.00K-159.13M-55.50M-52.05M-21.38M6.19M31.99M8.84M
Net Income Margin-13.10%10.60%0.03%-74.31%-26.70%-31.77%-10.55%2.41%10.03%2.58%
R&D2.98M2.59M2.79M7.84M5.00M4.90M2.97M3.38M4.52M6.16M
R&D as % of Total Revenue1.31%1.54%1.30%3.66%2.40%2.99%1.47%1.32%1.42%1.80%
Interest Expense2.28M2.55M1.54M1.66M1.12M832.00K681.00K965.00K1.26M2.46M
Interest Expense % of Total Revenue1.00%1.52%0.72%0.77%0.54%0.51%0.34%0.38%0.39%0.72%

Balance Sheet

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets317.86M337.94M314.64M363.17M249.04M168.23M157.69M190.36M256.11M325.92M
Total Liabilities190.40M190.85M110.73M170.89M111.18M82.41M93.21M119.96M153.71M215.31M
Total Equity127.45M147.09M203.91M192.29M137.86M85.82M64.48M70.41M102.39M110.61M
Cash16.17M13.72M89.32M50.16M52.07M38.95M40.58M46.63M82.94M89.20M
Total Debt116.81M138.42M51.40M64.65M40.43M31.60M30.32M55.04M69.98M-
Net Debt100.64M124.71M-37.92M14.49M-11.64M-7.34M-10.25M8.41M-12.97M-

Cash Flow

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-52.03M-53.26M-26.86M-63.28M4.48M-12.40M11.71M8.84M34.25M7.63M
Investing Cash Flow20.58M27.95M126.75M-45.42M1.43M9.88M-2.31M-13.65M-9.64M-
Financing Cash Flow23.93M21.36M-24.24M73.85M-1.25M-10.61M-9.28M10.85M11.71M-
Capital Expenditure9.88M3.50M12.42M45.42M16.74M3.40M326.00K1.25M11.43M15.02M
Free Cash Flow-61.91M-56.76M-39.28M-108.70M-14.11M-15.80M12.85M7.59M22.82M-7.39M
FCF to OCF119.00%106.56%146.23%171.78%-314.70%127.39%109.76%85.89%66.63%-96.82%

Key Statistics & Ratios

Market Cap160.26M
Enterprise Value208.97M
Trailing P/E23.71
Forward P/E0.00
Price / Sales0.43
Price / Book1.43
EPS0.35
Book Value5.89
Revenue (TTM)372.36M
Gross Profit (TTM)101.67M
EBITDA12.11M
Profit Margin1.77%
Operating Margin0.72%
Return on Equity5.95%
Return on Assets0.70%
Shares Outstanding19.31M
Shares Float13.14M
Beta-0.76
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jan 21, 2021769.28:1000